OptiBiotix Health (STU:OB3) EV-to-FCF: -3.18 (As of Jul. 06, 2026)


What is OptiBiotix Health EV-to-FCF?

OptiBiotix Health STU:OB3 +1.39% EV-to-FCF is -3.18 as of Jul. 06, 2026. The stock has 4 warning signs investors should review. Among 330 Biotechnology companies, OptiBiotix Health ranks worse than 303030% on this metric.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, OptiBiotix Health's Enterprise Value is €6.52 Mil. OptiBiotix Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.05 Mil. Therefore, OptiBiotix Health's EV-to-FCF for today is -3.18.

The historical rank and industry rank for OptiBiotix Health's EV-to-FCF or its related term are showing as below:

STU:OB3' s EV-to-FCF Range Over the Past 10 Years
Min: -57.93   Med: -23.36   Max: -2.33
Current: -3.18

During the past 13 years, the highest EV-to-FCF of OptiBiotix Health was -2.33. The lowest was -57.93. And the median was -23.36.

STU:OB3's EV-to-FCF is ranked worse than
100% of 330 companies
in the Biotechnology industry
Industry Median: 16.3 vs STU:OB3: -3.18

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-06), OptiBiotix Health's stock price is €0.073. OptiBiotix Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.045. Therefore, OptiBiotix Health's PE Ratio (TTM) for today is At Loss.


OptiBiotix Health  (STU:OB3) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

OptiBiotix Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.073/-0.045
=At Loss

OptiBiotix Health's share price for today is €0.073.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OptiBiotix Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.045.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


OptiBiotix Health EV-to-FCF Related Terms


OptiBiotix Health EV-to-FCF Historical Data

* Premium members only.

The historical data trend for OptiBiotix Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OptiBiotix Health EV-to-FCF Chart

OptiBiotix Health Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.34 -8.64 -15.56 -9.55 -3.35

OptiBiotix Health Semi-Annual Data
Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.56 0.00 -9.55 0.00 -3.35

STU:OB3 vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, OptiBiotix Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiBiotix Health EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's EV-to-FCF falls into.



OptiBiotix Health EV-to-FCF Calculation

OptiBiotix Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6.522/-2.053
=-3.18

OptiBiotix Health's current Enterprise Value is €6.52 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OptiBiotix Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of -3.18 mean?
OptiBiotix Health (STU:OB3) has a EV-to-FCF of -3.18 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on OptiBiotix Health and its competitors. According to the industry distribution chart, OptiBiotix Health ranks #999999 out of 330 companies in the Biotechnology industry.
Is OptiBiotix Health's EV-to-FCF too high?
OptiBiotix Health's current EV-to-FCF is -3.18. Based on the distribution chart, OptiBiotix Health ranks #999999 out of 330 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does OptiBiotix Health's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OptiBiotix Health ranks #999999 out of 330 companies for EV-to-FCF. This places OptiBiotix Health in the lower half of its industry. The industry median EV-to-FCF is 16.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.30, based on 330 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on OptiBiotix Health and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OptiBiotix Health's current EV-to-FCF is -3.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptiBiotix Health stock overvalued right now?
OptiBiotix Health (STU:OB3) has a current EV-to-FCF of -3.18. The stock's GF Value™ is €0.34, compared to a current price of €0.07 — trading 78.5% below its estimated fair value. The current EV-to-FCF is -3.18. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For OptiBiotix Health (STU:OB3), the current EV-to-FCF is -3.18 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OptiBiotix Health Business Description

Other Exchanges OPTI:UK
Address Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.